ААР — Американская академия педиатрии (American Academy of Pediatrics)
ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
АВСА3 — белковый член АТФ-связывающей кассеты АЗ
АВСВ11 — ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, subfamily В member 11)
АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
АВСС2 — ген, кодирующий 2-й член подсемейства С ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability-Exposure)
ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (Th eheterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
AC — до еды (при назначениях) — ante cibum
АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
AHA — Американская кардиологическая ассоциация (American Heart Association)
AIS — аденокарцинома in situ (adenocarcinoma in situ)
ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AUC — площадь под фармакокинетической кривой (area under the curve)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
ABCC2 - АТФ-связывающих кассет (ATP-binding cassette sub-family C member 2)
mTOR — мишень рапамицина в клетках млекопитающих (mammalian target ofrapamycin)
NB! — важно, обратить внимание (Nota bene)
NCI — Национальный институт рака (National Cancer Institute)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer)
NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
NMDA — N-метил-D-аспартатные рецепторы
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа PCSK-9 — пропротеиновая конвертаза субтилизин-кексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PD — плотность мощности (power density)
PD-1 — программируемая клеточная смерть 1 (англ. programmed cell death 1)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
piO2 — парциальное давление кислорода
во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы у
POP — пролапс тазовых органов (pelvic organ prolapse) POP-Q — количественная оценка пролапса тазовых органов (Pelvic Organ Prolapse Quantification)
PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS. — примечание (Post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) — quaque... hora
QAM — каждое утро (при назначениях) — quaque ante meridiem
QPM — каждый вечер (при назначениях) — quaque post meridiem
RAG — ген, активирующий рекомбиназу
REMS — Программа по оценке и снижению риска (Risk Evaluation and Mitigation Strategy)
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«+» — резус-положительный
Rh«-» — резус-отрицательный
ROCA — Алгоритм риска развития рака яичников (Risk of Ovarian Cancer Algorithm)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
ROMA — Алгоритм риска наличия злокачественной опухоли яичника (Risk of Ovarian Malignancy Algorithm)
RR — относительный риск (relative risk или risk ratio)
RW — реакция Вассермана (reaction of Wassermann)
SaO2 — сатурация артериальной крови кислородом
SatO2 — насыщение крови кислородом
SCJ — зона перехода плоского эпителия в цилиндрический (Scuamocolumnar Junction)
ScvO2 — насыщение кислородом центральной венозной крови (central venous oxygen saturation)
SD — стандартное отклонение (standart deviation) SEER — эпидемиология эпиднадзора и данных о конечных результатах (Surveillance Epidemiology and End Result)
SFTPA — ген сурфактантного белка A
SFTPB — ген сурфактантного белка В
SFTPC — ген сурфактантного белка С
SILS — хирургия единого лапароскопического доступа (single-incision laparoscopic surgery)
В ходе подготовки статей по психосоциальным и сексуальным проблемам женщин в гинекологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Achilli C, Pundir J, Ramanathan P et al. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril 107(2):475, 2017
Althof S: Sex therapy and combined (sex and medical) therapy. J Sex Med 8(6):1827, 2011
Althof SE, Leiblum SR, Chevret-Measson M et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2(6):793, 2005
American College of Obstetricians and Gynecologists: Screening for perinatal depression. Committee Opinion No. 757, November 2018
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, American Psychiatric Association, 2000
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, American Psychiatric Association, 2013
Andersen BL: A comparison of systematic desensitization and directed masturbation in the treatment of primary orgasmic dysfunction in females. J Consult Clin Psychol 49(4):568, 1981
Anderson E, Reti I: ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 71:235, 2009
Annon J: The PLISSIT model: a proposed conceptual scheme for the behavioral treatment of sexual problems. J Sex Educ Ther 2(1):1, 1976
Atlantis E, Sullivan T: Bidirectional association between depression and sexual dysfunction: a systematic review and metaanalysis. J Sex Med 9(6):1497, 2012
Backstram T, Bixo M, Johansson M et al. Allopregnanolone and mood disorders. Prog Neurobiol 113:88, 2014
Baller EB, Wei SM, Kohn PD et al. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry 170(3):305, 2013
Basson R: Taking the sexual history, part 1: eliciting the sexual concerns of your patient in primary care. Med Aspects Hum Sex 1(1):13, 2000
Basson R, Schultz WW: Sexual sequelae of general medical disorders. Lancet 369(9559):409, 2007
Bergeron S, Corsini-Munt S, Aerts L et al. Female sexual pain disorders: a review of the literature on etiology and treatment. Curr Sex Health Rep 7(3):159, 2015
Bergeron S, Morin M, Lord MJ: Integrating pelvic floor rehabilitation and cognitive-behavioral therapy for sexual pain: what have we learned and where do we go from here? Sex Relat Ther 25(3):289, 2010
Bloch M, Rotenberg N, Koren D et al. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 28(1):3, 2006
Boyce P, Hickey A: Psychosocial risk factors to major depression after childbirth. Soc Psychiatry Psychiatr Epidemiol 40(8):605, 2005
Bradford A: Inhibited sexual desire in women. In Grossman L, Walfish R (eds): Translating Psychological Research into Practice. New York, Springer, 2014, p 515
Brandon AR, Crowley SK, Gordon JL et al. Non-pharmacologic treatments for depression related to reproductive events. Curr Psychiatr Rep 16 (12), 526, 2014
Braun DL, Sunday SR, Halmi KA: Psychiatric comorbidity in patients with eating disorders. Psychol Med 24(4):859, 1994
Braunstein GD, Sundwall DA, Katz M et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165(14):1582, 2005
Brink TL, Yesavage JA, Lum O et al. Screening tests for geriatric depression. Clin Gerontol 1(1):37, 1982
Bromberger JT, Meyer PM, Kravitz HM et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 91(9):1435, 2001
Brotto LA, Basson R: Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther 57:43, 2014
Brotto LA, Basson R, Smith KB et al. Mindfulness-based group therapy for women with provoked vestibulodynia. Mindfulness 6:417, 2015
Burnett AL, Goldstein I, Andersson KE et al. Future sexual medicine physiological treatment targets. J Sex Med 7(10):3269, 2010
Burrows LJ, Goldstein AT: The treatment of vestibulodynia with topical estradiol and testosterone. Sex Med 1(1):30, 2013
Buster JE, Kingsberg SA, Aguirre O et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105(5 Pt 1):944, 2005
Caruso S, Rugolo S, Agnello C et al. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril 85(5):1496, 2006
Centre for Maternal and Child Enquiries: Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. BJOG 118(Suppl 1): 1, 2011
Clayton A, Althof S, Kingsberg S et al. Bremelanotide for female sexual dysfunction in premenopausal women: a randomized placebo-controlled dose-finding trial. Womens Health 12(3):325, 2016
Clayton A, Kingsberg S, Simon J et al. Safety and efficacy of bremelanotide for HSDD in women: RECONNECT study open-label extension phase results. Presented at Annual Meeting of the American College of Obstetricians and Gynecologists, 27–30 April 2018
Clayton AH, El Haddad S, Iluonakhamhe JP et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf 13(10):1361, 2014
Clayton AH, Goldfischer ER, Goldstein I et al. Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 6(3):730, 2009
Clayton AH, Goldstein I, Kim NN et al. The International Society for the Study of Women’s Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 93(4):467, 2018
Cobin RH, Goodman NF et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause-2017 update. Endocr Pract 23(7):869, 2017
Cohen LS, Altshuler LL, Harlow BL et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499, 2006a
Cohen LS, Soares CN, Vitonis AF et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63(4):385, 2006b
Cox J, Holden J, Sagovsky R: Detection of postnatal depression: development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry 150:782, 1987
Cronje WH, Vashisht A, Studd JW: Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 19:2152, 2004
Culbert KM, Racine SE, Klump KL: Research review: what we have learned about the causes of eating disorders—a synthesis of sociocultural, psychological, and biological research. J Child Psychology Psychiatry 56(11):1141, 2015
Dashe JS, Cunningham FG: Teratology, teratogens, and fetotoxic agents. In Cunningham FG, Leveno KJ, Bloom SL, et al (eds): Williams Obstetrics, 25th ed. New York, McGraw-Hill, 2018, p 238
Davis SR, Bitzer J, Giraldi A et al. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction. J Sex Med 10(12):3069, 2013
Davis SR, Braunstein GD: Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 9(4):1134, 2012
Davis SR, Moreau M, Kroll R et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359(19):2005, 2008
De Souza MC, Walker AF, Robinson PA et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 9(2):131, 2000
Deligiannidis KM, Freeman MP: Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol 28(1):85, 2014
DeRogatis LR, Clayton AH, Rosen RC: Should sexual desire and arousal disorders in women be merged? Arch Sex Behav 40(2):217, 2011
DeRogatis LR, Edelson J, Jordan R et al. Bremelanotide for female sexual dysfunctions: responder analyses from a phase 2B dose-ranging study. Obstet Gynecol 123(Suppl 1):26s, 2014
DeRogatis LR, Komer L, Katz M et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. J Sex Med 9(4):1074, 2012
DeRogatis LR, Rosen R, Leiblum S et al: The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 28(4):317, 2002
DiMarco MA, Menke EM, McNamara T: Evaluating a support group for perinatal loss. MCN Am J Matern Child Nurs 26(3):135, 2001
Engel GL: The need for a new medical model: a challenge for biomedicine. Science 196(4286):129, 1977
Erikson EH: Childhood and Society, 2nd ed. New York, Norton, 1963
Field T, Diego M, Hernandez-Reif M et al. Yoga and massage therapy reduce prenatal depression and prematurity. J Body Mov Ther 16(2):204, 2012
Flenady V, Boyle F, Koopmans L et al. Meeting the needs of parents after a stillbirth or neonatal death. BJOG 121(Suppl 4):137, 2014
Flynn KE, Tessler Lindau S et al. Development and validation of a single-item screener for self-reporting sexual problems in U.S. adults. J Gen Intern Med 30(10):1468, 2015
Food and Drug Administration: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. 2011a. Available at: http://www.fda.gov/Drugs/ DrugSafety/ucm243903.htm. Accessed November 30, 2018
Food and Drug Administration: Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. 2014. Available at: http://federalregister.gov/a/2014-28241. Accessed November 30, 2018
Food and Drug Administration: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. 2011b. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm283375.htm. Accessed November 30, 2018
Food and Drug Administration: Selective serotonin reuptake inhibitors (SSRIs), selective serotonin-norepinephrine reuptake inhibitors (SNRIs), 5-hydroxytryptamine receptor agonists (triptans), 2006. Available at: https://www.fda.gov/drugs/information-drug-class/selective-serotonin-reuptake-inhibitors-ssris-information Accessed November 30, 2018
Freeman EW, Sammel MD, Lin H et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63(4):375, 2006
Gaynes BN, Gavin N, Meltzer-Brody S et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess 119:1, 2005
Goldstein I, Kim NN, Clayton AH et al. Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc 92(1):114, 2017
Gott M, Galena E, Hinchliff S et al. “Opening a can of worms”: GP and practice nurse barriers to talking about sexual health in primary care. Fam Pract 21(5):528, 2004
Gressier F, Rotenberg S, Cazas O et al. Postpartum electroconvulsive therapy: a systematic review and case report. Gen Hosp Psychiatry 37(4):310, 2015
Guthrie KA, LaCroix AZ, Ensrud KE et al. Pooled analysis of six pharmacologic and nonpharmacologic interventions for vasomotor symptoms. Obstet Gynecol 126(2):413, 2015
Halbreich U: The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28(Suppl 3):55, 2003a
Halbreich U, Borenstein J, Pearlstein T et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28(Suppl 3):1, 2003b
Hatzichristou D, Rosen RC, Broderick G et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 1(1):49, 2004
Heiman JR, LoPiccolo J: Becoming Orgasmic: a Sexual and Personal Growth Program for Women (revised and expanded edition). New York, Simon & Schuster, 1988
Hoek HW: Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19(4):389, 2006
Hobel C, Lepp? V, Breen G et al. Rigor and reproducibility in genetic research on eating disorders. Int J Eat Dis 51(7):593, 2018
Jayne C, Simon JA, Taylor LV et al. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder. J Sex Med 9(12):3180, 2012
Kanes S, Colguhoun H, Gundez-Bruce H et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 390(10093):480, 2017
Kaplan PS, Burgess AP, Sliter JK et al. Maternal sensitivity and the learning-promoting effects of depressed and nondepressed mothers’ infant-directed speech. Infancy 14(2):143, 2009
Katz M, DeRogatis LR, Ackerman R et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med 10(7):1807, 2013
Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593, 2005
Kingsberg SA: Taking a sexual history. Obstet Gynecol Clin N Am 33(4):535, 2006
Kingsberg SA, Althof A, Simon JA et al. Female sexual dysfunction—medical and psychological treatments, Committee 14. J Sex Med 14(12):1463, 2017
Kingsberg SA, Clayton AG, Pfaus JG: The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs 29(11):915, 2015
Kingsberg SA, Janata J: Female sexual disorders: assessment, diagnosis, and treatment. Urol Clin North Am 34(4):497, 2007
Kolar DR, Rodriguez DL, Chams MM et al. Epidemiology of eating disorders in Latin America: a systematic review and meta-analysis. Curr Opin Psychiatry 29(6):363, 2016
Laan E, van Lunsen RH, Everaerd W: The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 4(1):28, 2001
Lancaster CA, Gold KJ, Flynn HA et al. Risk factors for depressive symptoms during pregnancy: a systematic review. Am J Obstet Gynecol 202(1):5, 2010
Laurent SM, Simons AD: Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. Clin Psychol Rev 29(7):573, 2009
Levin RJ: The pharmacology of the human female orgasm—its biological and physiological backgrounds. Pharmacol Biochem Behav 121:62, 2014
Luftey KE, Link CL, Litman HJ et al: An examination of the association of abuse (physical, sexual, or emotional) and female sexual dysfunction: results from the Boston Area Community Health Survey. Fertil Steril 90(4):957, 2008
Luppa M, Sikorski C, Luck T et al. Age- and gender-specific prevalence of depression in latest-life—systematic review and meta-analysis. J Affect Disord 136(3):212, 2012
Maartens LWF, Knottnerus JA, Pop VJ: Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 42(3):195, 2002
Maki PM, Kornstein SG, Joffe H et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 25(10):1069, 2018
Manber R, Schnyer RN, Lyell D et al. Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol 115(3):511, 2010
Mangweth-Matzek B, Hoek HW, Pope HG: Pathological eating and body dissatisfaction in middle-aged and older women. Curr Opin Psychiatry 27:431, 2014
Maravilla KR, Yang CC: Magnetic resonance imaging and the female sexual response: overview of techniques, results, and future directions. J Sex Med 5(7):1559, 2008
Marjoribanks J, Brown J, O’Brien PM et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 6:CD001396, 2013
Marwick C: Survey says patients expect little physician help on sex. JAMA 281(23):2173, 1999
Masheb RM, Kerns RD, Lozano C et al. A randomized clinical trial for women with vulvodynia: cognitive behavioral therapy vs. supportive psychotherapy. Pain 141(1–2):31, 2009
McCabe MP, Sharlip ID, Atalla E: Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth International Consultation on Sexual Medicine 2015. J Sex Med 13(2):135, 2016
McMullen S, Rosen RC: Self-administered masturbation training in the treatment of primary orgasmic dysfunction. J Consult Clin Psychol 47(5):912, 1979
Meltzer-Brody S, Colguhoun H, Riesenberg R et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet 392(10152):1058, 2018
Mitchell AM, Bulik CM: Eating disorders and women’s health: an update. J Midwifery Womens Health 51(3):193, 2006
Nappi RE, Cucinella L: Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opin Pharmacother 16(6):875, 2015
National Institute of Mental Health: Major Depression. 2016. Available at: https://www.nimh.nih.gov/health/statistics/major-depression.shtml. Accessed November 30, 2018
Nevatte T, O’Brien PM, B?ckstr?m T et al. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 16(4):279, 2013
Newport DJ, Wilcox MM, Stowe ZN: Maternal depression: a child’s first adverse life event. Semin Clin Neuropsychiatry 7(2):113, 2002
Nobre PJ, Pinto-Gouveia J: Cognitions, emotions, and sexual response: analysis of the relationship among automatic thoughts, emotional responses, and sexual arousal. Arch Sex Behav 37(4):652, 2008
North American Menopause Society: The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24(7):728, 2017
Oral E, Kirkan TS, Yildirim A et al. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder. Gen Hosp Psychiatry 37(3):266, 2015
Ossewaarde L, van Wingen GA, Rijpkema M et al. Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity. Hum Brain Mapp 34:1187, 2013
Palha A, Esteves M: Drugs of abuse and sexual functioning. Adv Psychosom Med 29:131, 2008
Parish SJ, Goldstein AT, Goldstein SW: Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions—Part II. J Sex Med 13(12):1888, 2016
Pauls RC, Kleeman SD, Karram MM: Female sexual dysfunction: principles of diagnosis and therapy. Obstet Gynecol Surv 60(3):196, 2005
Pearlstein TB, Bachmann GA, Zacur HA et al. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 72:414, 2005
Perelman MA: Clinical application of CNS-acting agents in FSD. J Sex Med 4(Suppl 4):280, 2007
Pfaus J, Giuliano F, Gelez H: Bremelanotide: an overview of preclinical CNS effects on female sexual function. J Sex Med 4(Suppl 4):269, 2007
Phillips NA: The clinical evaluation of dyspareunia. Int J Impot Res 10(Suppl 2): S117, 1998
Pike KM, Dunne PE: The rise of eating disorders in Asia: a review. J Eat Disord 17(3):33, 2015
Pinheiro AP, Raney TJ, Thornton LM et al. Sexual functioning in women with eating disorders. Int J Eat Disord 43(2):123, 2010
Pinquart M, Duberstein PR: Treatment of anxiety disorders in older adults: a meta-analytic comparison of behavioral and pharmacological interventions. Am J Geriatr Psychiatry 15(8):639, 2007
Pinquart M, Duberstein PR, Lyness JM: Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry 163(9):1493, 2006
Poels S, Bloemers J, van Rooij K et al. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med 10(3):810, 2013
Polidori MC, Menculini G, Senin U et al. Dementia, depression and parkinsonism: a frequent association in the elderly. J Alzheimer Dis 3(6):553, 2001
Portman DJ, Brown L, Yuan J et al. Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study. J Sex Med 14(6):834, 2017
Portman DJ, Edelson J, Jordan R et al. Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study. Obstet Gynecol 123(Suppl 1):31s, 2014
Pyke RE, Clayton A: Models vs. realities in female sexual dysfunction. J Sex med 12(9):1977, 2015
Quirk FH, Heiman JR, Rosen RC: Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 11(3):277, 2002
Reid RL, Soares CN: Premenstrual dysphoric disorder: contemporary diagnosis and management. J Obstet Gynaecol Can 40(2):215, 2018
Riley AJ, Riley EJ: A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women. Br J Psychiatry 133:404, 1978
Risen CB: A guide to taking a sexual history. Psychiatr Clin N Am 18(1):39, 1995
Rosen R, Brown C, Heiman J et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191, 2000
Rundgren S, Brus O, B?ve U et al. Improvement of postpartum depression and psychosis after electroconvulsive therapy: a population-based study with a matched comparison group. J Affect Disord 235:258, 2018
Rush AJ, Trivedi MH, Ibrahim HM et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54(5):573, 2003
Sayil M, Gure A, U?anok Z: First time mothers’ anxiety and depressive symptoms across the transition to motherhood: associations with maternal and environmental characteristics. Women Health 44(3):61, 2007
Schoen C, Bachmann G: Sildenafil citrate for female sexual arousal disorder: a future possibility? Nat Rev Urol 6(4):216, 2009
Segraves RT, Clayton A, Croft H et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 24(3):339, 2004
Shah NR, Jones JB, Aperi J et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175, 2008
Sharma V, Mazmanian D: The DSM-5 peripartum specifier: prospects and pitfalls. Arch Womens Ment Health 17(2):171, 2014
Shifren JL: Testosterone for midlife women: the hormone of desire? Menopause 22(10):1147, 2015
Shifren JL, Monz BU, Russo PA: Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 112(5): 970, 2008
Shindel AW, Parish SJ: Sexuality education in North American medical schools: current status and future directions. J Sex Med 10(1):3, 2013
Shivakumar G, Brandon AR: Antenatal depression: a rationale for studying exercise. Depress Anxiety 28(3): 234, 2011
Shorey S, Chee CYI, Ng ED et al. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res 104:235, 2018
Sie SD, Wennink JM, van Driel JJ et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed 97(6):F472, 2012
Simon JA, Kingsberg SA, Shumel B et al. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause 21(6):633, 2013
Soares CN, Almeida OP, Joffe H: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58(6):529, 2001
Sockol LE: A systematic review and meta-analysis of interpersonal psychotherapy for perinatal women. J Affect Disord 232:316, 2018
Sockol LE: A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord 177:7, 2015
Solmaz V, Ceviz A, Aksoy D et al. Sexual dysfunction in women with migraine and tension-type headaches. Int J Impot Res 28(6):201, 2016
Solursh D, Ernst J, Lewis R et al. The human sexuality education of physicians in North American medical schools. Int J Impot Res 15(Suppl 5): 41, 2003
Stoving RK, Hangaard J, Hagen C: Update on endocrine disturbances in anorexia nervosa. J Pediatr Endocrinol 14(5):459, 2001
Strumia R: Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 6(3):165, 2005
Stuart S, Koleva H: Psychological treatments for perinatal depression. Best Pract Res Clin Obstet Gynaecol 28(1):61, 2014
Su KP, Huang SY, Chiu TH et al. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69(4):644, 2008
Substance Abuse and Mental Health Services Administration: Results from the 2012 National Survey on Drug Use and Health: mental health findings. NSDUH Series H-47, HHS Publication No. (SMA) 13–4805, Rockville, 2013
ter Kuile MK, Both S, van Lankveld JJ: Cognitive behavioral therapy for sexual dysfunctions in women. Psychiatr Clin N Am 33(3): 595, 2010
ter Kuile MM, Melles R, de Groot HE: Therapist-aided exposure for women with lifelong vaginismus: a randomized waiting-list control trial of efficacy. J Consult Clin Psychol 81(6):1127, 2013
Thomas JJ, Lee S, Becker AE: Updates in the epidemiology of eating disorders in Asia and the Pacific. Curr Opin Psychiatry 29(6):354, 2016
Thorp J, Simon J, Dattani D et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 9(3):793, 2012
Thys-Jacobs S: Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr 19(2):220, 2000
Trace SE, Baker JH, Pe?as-Lled? E et al. The genetics of eating disorders. Annu Rev Clin Psychol 9:589, 2013
Tuiten A, van Honk J, Verbaten R et al. Can sublingual testosterone increase subjective and physiological measures of laboratory induced sexual arousal? Arch Gen Psychiatry 59(5):465, 2002
Tuiten A, van Rooij K, Bloemers J et al. Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/ arousal disorder: 3 randomized clinical trials. J Sex Med 15(2):201, 2018
United States Census Bureau: Older people projected to outnumber children for first time in US History. 2018. Available at https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html. Accessed January 5, 2019
Van Lankveld JJ, Granot M, Weijmar Schultz WC et al. Women’s sexual pain disorders. J Sex Med 7(1 Pt 2):615, 2010
van Rooij K, Poels S, Bloemers J et al. Toward personalized sexual medicine (part 3): testosterone combined with a serotonin 1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. J Sex Med 10(3): 824, 2013
VanderKruik R, Barreix M, Chou D et al. The global prevalence of postpartum psychosis: a systematic review. BMC Psychiatry 17(1):272, 2017
Volkert J, Schulz H, H?rter M et al. The prevalence of mental disorders in older people in Western countries—a meta-analysis. Ageing Res Rev 12(1): 339, 2013
Wallwiener M, Wallwiener LM, Seeger H et al. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception 82(2):155, 2010
Wang M, Seippel L, Purdy RH et al. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81(3):1076, 1996
Weaver TL: Impact of rape on female sexuality: review of selected literature. Clin Obstet Gynecol 52(4): 702, 2009
Wirz-Justice A, Bader A, Frisch U et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry 72(7):986, 2011
Wittchen HU, Becker E, Lieb R et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32(1): 119, 2002
Woody CA, Ferrari AJ, Siskind DJ et al. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord 219:86, 2017
World Health Organization: Defining sexual health: report of a technical consultation on sexual health, 28–31 January 2002, Geneva, 2006. Available at: https://www.who.int/teams/sexual-and-reproductive-health-and-research/key-areas-of-work/sexual-health/defining-sexual-health. Accessed December 15, 2018
Wyatt KM, Dimmock PW, Ismail KM et al. The effectiveness of GnRHa with and without “add-back” therapy in treating premenstrual syndrome: a meta-analysis. BJOG 111:585, 2004
Wyatt KM, Dimmock PW, Jones PW et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318:1375, 1999
Yehuda R, Lehrner A, Rosenbaum TY: PTSD and sexual dysfunction in men and women. J Sex Med 12(5):1107, 2015
Yonkers KA, Brown C, Pearlstein TB et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492, 2005
Yonkers KA, Wisner KL, Stewart DE et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 31(5):403, 2009
Труды отечественных авторов при подготовке статей по гинекологии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
